The current use and future trends of focal surgical therapy in the management of localized prostate cancer

Cancer Journal

Volumn 13, Issue 5, 2007, Pages 313-317

  Barqawi, Al B ^a,b   Crawford, E David ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b Section of Urologic Oncology   (United States)

Author keywords

Localized disease; Minimally invasive treatment; Prostate cancer

Indexed keywords

CANCER LOCALIZATION; CANCER SURGERY; CRYOTHERAPY; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; QUALITY OF LIFE; REVIEW; CRYOSURGERY; IMMUNOLOGY; IMMUNOTHERAPY; MALE; MINIMALLY INVASIVE SURGERY; MULTIMODALITY CANCER THERAPY; PHOTOCHEMOTHERAPY; PROSTATE TUMOR;

COMBINED MODALITY THERAPY; CRYOSURGERY; HUMANS; IMMUNOTHERAPY; MALE; PHOTOCHEMOTHERAPY; PROSTATIC NEOPLASMS; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

EID: 38449084705     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0b013e318156eb99     Document Type: Review

References (36)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. Etzioni R, Penson DF, Legler JM, et al. Overdiagnosis due to prostatespecific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst. 2002;94:981-990.
3. Thompson I, Thrasher JB, Aus G, et al. Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update. Baltimore, MD: Americam Urological Association, 2007.
4. Miller DC, Gruber SB, Hollenbeck BK, et al. Incidence of initial local therapy among men with lower-risk prostate cancer in the United States. J Natl Cancer Inst. 2006;98:1134-1141.
5. Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer: Scandinavian Prostate Cancer Group Study No. 4. N Engl J Med. 2005;352:1977-1984.
6. Shrader-Bogen CL, Kjellberg JL, McPherson CP, et al. Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy. Cancer. 1997;79:1977-1986.
7. Eton DT, Lepore SJ, Helgeson VS. Early quality of life in patients with localized prostate carcinoma: an examination of treatment-related, demographic, and psychosocial factors. Cancer. 2001;92:1451-1459.
8. Zhang J, Sandison GA, Murthy JY, et al. Numerical simulation for heat transfer in prostate cancer cryosurgery. J Biomech Eng. 2005;127:279 -294.
9. Baust JG, Gage AA, Clarke D, et al. Cryosurgery - a putative approach to molecular-based optimization. Cryobiology. 2004;48:190-204.
10. Theodorescu D. Cancer cryotherapy. evolution and biology. Rev Urol. 2004;6:S9-S19.
11. Saliken JC, Donnelly BJ, Rewcastle JC. The evolution and state of modern technology for prostate cryosurgery. Urology. 2002;60:26-33.
12. Wong WS, Chinn DO, Chinn M, et al. Cryosurgery as a treatment for prostate carcinoma: results and complications. Cancer. 1997;79:963-974.
13. Robinson MR, Moul JW. Novel techniques for the treatment of localized prostate cancer: evidence of efficacy? Curr Urol Rep. 2007;8:203-210.
14. Aus G. Current status of HIFU and cryotherapy in prostate cancer - a review. Eur Urol. 2006;50:927-934; discussion 934.
15. Bahn DK, Lee F, Badalament R, et al. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology. 2002;60:3-11.
16. Donnelly BJ, Saliken J, Brasher P, et al. A randomized controlled trial comparing external beam radiation and cryoablation in localized prostate cancer. In: Proceedings from the Annual Meeting of the American Urological Association, Anaheim, CA, 2007:abstract 1141.
17. Jones JS, Donnelly BJ, Pisters LL, et al. Primary prostate cryoablation: results from 1198 patients tracked with the Cold Registry. In: Proceedings from the Annual Meeting of the American Urological Association, Anaheim, CA, 2007:abstract 1773.
18. Prepelica KL, Okeke Z, Murphy A, et al. Cryosurgical ablation of the prostate: high risk patient outcomes. Cancer. 2005;103:1625-1630.
19. Cresswell J, Asterling S, Chaudhary M, et al. Third-generation cryother-apy for prostate cancer in the UK: a prospective study of the early outcomes in primary and recurrent disease. BJU Int. 2006;97:969-974.
20. Anastasiadis AG, Sachdev R, Salomon L, et al. Comparison of health-related quality of life and prostate-associated symptoms after primary and salvage cryotherapy for prostate cancer. J Cancer Res Clin Oncol. 2003;129:676-682.
21. Donnelly BJ, Saliken JC, Ernst DS, et al. Prospective trial of cryosurgical ablation of the prostate: five-year results. Urology. 2002;60:645- 649.
22. Ellis DS, Manny TB Jr, Rewcastle JC. Cryoablation as primary treatment for localized prostate cancer followed by penile rehabilitation. Urology. 2007;69:306-310.
23. Machlenkin A, Goldberger O, Tirosh B, Paz A, et al. Combined dendritic cell cryotherapy of tumor induces systemic antimetastatic immunity. Clin Cancer Res. 2005;11:4955-4961.
24. Chavrier F, Chapelon JY, Gelet A, et al. Modeling of high-intensity focused ultrasound-induced lesions in the presence of cavitation bubbles. J Acoust Soc Am. 2000;108:432-440.
25. Gelet A, Chapelon JY, Bouvier R, et al. Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience. Eur Urol. 1996;29:174-183.
26. Beerlage HP, Thuroff S, Debruyne FM, et al. Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma. Urology. 1999;54:273-277.
27. Thuroff S, Chaussy C, Vallancien G, et al. High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. J Endourol. 2003;17:673-677.
28. Uchida T, Baba S, Irie A, et al. Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer: a multicenter study. Hinyokika Kiyo. 2005;51:651-658.
29. Gelet A, Chapelon JY, Bouvier R, et al. Transrectal high-intensity focused ultrasound: minimally invasive therapy of localized prostate cancer. J Endourol. 2000;14:519-528.
30. Ficarra V, Antoniolli SZ, Novara G, et al. Short-term outcome after high-intensity focused ultrasound in the treatment of patients with high-risk prostate cancer. BJU Int. 2006;98:1193-1198.
31. Poissonnier L, Chapelon JY, Rouviere O, et al. Control of prostate cancer by transrectal HIFU in 227 patients. Eur Urol. 2007;51:381-387.
32. Huang Z. A review of progress in clinical photodynamic therapy. Technol Cancer Res Treat. 2005;4:283-293.
33. Moore CM, Nathan TR, Lees WR, et al. Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer. Lasers Surg Med. 2006;38:356-363.
34. Huang Z, Chen Q, Luck D, et al. Studies of a vascular-acting photosensi-tizer, Pd-bacteriopheophorbide (Tookad), in normal canine prostate and spontaneous canine prostate cancer. Lasers Surg Med. 2005;36:390 -397.
35. Du KL, Mick R, Busch TM, et al. Preliminary results of interstitial motexafin lutetium-mediated PDT for prostate cancer. Lasers Surg Med. 2006;38:427-434.
36. Crawford ED, Barqawi A. Targeted focal therapy: a minimally invasive ablation technique for early prostate cancer. Oncology (Williston Park). 2007;21:27-32; discussion 33-4, 39.